RT102（Regel Therapeutics）

N/A

Report date: 2025/09/25 17:32:33

Base Information

Drug NameRT102（Regel Therapeutics）
Drug Alias NameRT-102RT102
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionGene expression modulatorsSodium channel protein type II alpha subunit stimulants
TargetsSodium channel protein type II alpha subunit
Therapy Area/IndicationsGenetic Diseases, InbornCentral Nervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaN/A
Originator CompaniesRegel Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesRegel Therapeutics
Inactive CompaniesN/A
Active IndicationsGenetic Diseases, InbornCentral Nervous System Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A